Literature DB >> 27647307

The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.

Laura Mahoney-Sanchez1, Abdel Ali Belaidi1, Ashley I Bush1, Scott Ayton2.   

Abstract

Apolipoprotein E (ApoE) plays a crucial role in the homeostatic control of lipids in both the periphery and the central nervous system (CNS). In humans, ApoE exists in three different isoforms: ε2, ε3 and ε4. ApoE ε3 is the most common isoform, while the ε4 isoform confers the greatest genetic risk for Alzheimer's disease (AD). However, the mechanisms underlying how ApoE contributes to the pathogenesis of AD are still debated. ApoE has been shown to impact amyloid β (Aβ) deposition and clearance in the brain. ApoE also has Aβ-independent pathways in AD, which has led to the discovery of new roles of ApoE ranging from mitochondria dysfunction to, most recently, iron metabolism. Here, we review the role of ApoE in health and in AD, with the view of identifying therapeutic approaches that could prevent the risk associated with the ε4 isoform.

Entities:  

Keywords:  Alzheimer’s disease; Apolipoprotein E; Iron; Neurodegeneration; ε4

Mesh:

Substances:

Year:  2016        PMID: 27647307     DOI: 10.1007/s12031-016-0839-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  117 in total

1.  Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

Authors:  John M Ringman; David Elashoff; Daniel H Geschwind; Brian T Welsh; Karen H Gylys; Cathy Lee; Jeffrey L Cummings; Greg M Cole
Journal:  Arch Neurol       Date:  2012-06

Review 2.  Metallostasis in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Free Radic Biol Med       Date:  2012-11-09       Impact factor: 7.376

Review 3.  HDL and cholesterol handling in the brain.

Authors:  Cecilia Vitali; Cheryl L Wellington; Laura Calabresi
Journal:  Cardiovasc Res       Date:  2014-06-06       Impact factor: 10.787

4.  Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain.

Authors:  T M Hansen; H Nielsen; N Bernth; T Moos
Journal:  Brain Res Mol Brain Res       Date:  1999-03-05

Review 5.  Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease.

Authors:  Jerry R Colca; Douglas L Feinstein
Journal:  Adv Pharmacol       Date:  2012

6.  Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy.

Authors:  M A Kuiper; C Mulder; G J van Kamp; P Scheltens; E C Wolters
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1994

Review 7.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

8.  APOE genotype-specific differences in human and mouse macrophage nitric oxide production.

Authors:  Carol A Colton; Leila K Needham; Candice Brown; Danielle Cook; Karima Rasheed; James R Burke; Warren J Strittmatter; Donald E Schmechel; Michael P Vitek
Journal:  J Neuroimmunol       Date:  2004-02       Impact factor: 3.478

9.  Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

Authors:  W J Schneider; P T Kovanen; M S Brown; J L Goldstein; G Utermann; W Weber; R J Havel; L Kotite; J P Kane; T L Innerarity; R W Mahley
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  30 in total

1.  Dementia Research Australia: the Australian Dementia Research Development Fellowship Program.

Authors:  Ashley I Bush; George Fink; Peng Lei
Journal:  J Mol Neurosci       Date:  2016-11       Impact factor: 3.444

2.  Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.

Authors:  Shruti Mishra; Tyler M Blazey; David M Holtzman; Carlos Cruchaga; Yi Su; John C Morris; Tammie L S Benzinger; Brian A Gordon
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

3.  Protective Variants in Alzheimer's Disease.

Authors:  Shea J Andrews; Brian Fulton-Howard; Alison Goate
Journal:  Curr Genet Med Rep       Date:  2019-01-24

4.  Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy.

Authors:  Ashley I Bush; Scott Ayton; Abdel Ali Belaidi; Shashank Masaldan; Adam Southon; Pawel Kalinowski; Karla Acevedo; Ambili T Appukuttan; Stuart Portbury; Peng Lei; Puja Agarwal; Sue E Leurgans; Julie Schneider; Marcus Conrad
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

Review 5.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 6.  Genetic underpinnings of cerebral edema in acute brain injury: an opportunity for pathway discovery.

Authors:  Elayna Kirsch; Natalia Szejko; Guido J Falcone
Journal:  Neurosci Lett       Date:  2020-05-26       Impact factor: 3.046

7.  Targeting the accomplice to thwart the culprit: a new target for the prevention of amyloid deposition.

Authors:  David R Borchelt
Journal:  J Clin Invest       Date:  2018-03-30       Impact factor: 14.808

Review 8.  Precision hormone therapy: identification of positive responders.

Authors:  Y J Kim; R D Brinton
Journal:  Climacteric       Date:  2021-02-22       Impact factor: 3.005

9.  Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients.

Authors:  Laura Bianchi; Maria Sframeli; Lorenza Vantaggiato; Gian Luca Vita; Annamaria Ciranni; Francesca Polito; Rosaria Oteri; Eloisa Gitto; Fabrizio Di Giuseppe; Stefania Angelucci; Antonio Versaci; Sonia Messina; Giuseppe Vita; Luca Bini; M'hammed Aguennouz
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

10.  Expression and proteolytic processing of the amyloid precursor protein is unaffected by the expression of the three human apolipoprotein E alleles in the brains of mice.

Authors:  Mariah J Novy; Samantha F Newbury; Braison Liemisa; Jose Morales-Corraliza; Melissa J Alldred; Stephen D Ginsberg; Paul M Mathews
Journal:  Neurobiol Aging       Date:  2021-10-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.